Evidence map›Paper›PMID 42902934›Full record

ArticleChembiochem : a European journal of chemical biology2026

Characterization and Crystal Structure Elucidation of the l-Homoserine O-Succinyltransferase MetXS From Cupriavidus necator H16.

Hannah Pia Franziska Meier, Rick Oerlemans, Henrik Terholsen, Matthew R Groves, Lars Lauterbach, Sandy Schmidt

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hannah Pia Franziska MeierDepartment of Chemical and Pharmaceutical Biology, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.ORCID https://orcid.org/0000-0001-5765-9381
Rick OerlemansDepartment of Chemical and Pharmaceutical Biology, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.ORCID https://orcid.org/0000-0001-7114-3736
Henrik TerholsenDepartment of Chemical and Pharmaceutical Biology, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.ORCID https://orcid.org/0000-0001-9625-8177
Matthew R GrovesDepartment of Chemical and Pharmaceutical Biology, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.ORCID https://orcid.org/0000-0001-9859-5177
Lars LauterbachiAMB - Institute of Applied Microbiology, RWTH Aachen University, Aachen, Germany.ORCID https://orcid.org/0000-0002-6601-6473
Sandy SchmidtDepartment of Chemical and Pharmaceutical Biology, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.ORCID https://orcid.org/0000-0002-8443-8805

Funding

ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
$5.2M
H2020 Marie Skłodowska-Curie Actions 955740Nederlandse Organisatie voor Wetenschappelijk Onderzoek VI.Vidi.213.025NIGMS NIH HHS R01 GM129325
6 · The paper itself

Abstract

Among the promising microbial platforms to produce value-added products from CO

Indexed as

Cupriavidus necatorHomoserine O-SuccinyltransferaseCrystallography, X-RayHomoserineMethionineModels, MolecularHomoserineHomoserine O-SuccinyltransferaseMethionineacyltransferaseCupriavidus necatorhomoserine O‐succinyltransferasemethionine biosynthesisMetX

Identifiers

PMID42902934
PMCPMC13683966

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.